1,572 Shares in UiPath Inc. (NYSE:PATH) Purchased by GAMMA Investing LLC

GAMMA Investing LLC bought a new stake in shares of UiPath Inc. (NYSE:PATHFree Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 1,572 shares of the healthcare company’s stock, valued at approximately $36,000.

A number of other large investors also recently added to or reduced their stakes in the business. HighMark Wealth Management LLC purchased a new stake in UiPath during the 4th quarter valued at approximately $27,000. FNY Investment Advisers LLC bought a new position in shares of UiPath during the fourth quarter worth $40,000. FSC Wealth Advisors LLC purchased a new position in UiPath during the fourth quarter valued at $43,000. Fifth Third Bancorp increased its holdings in UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after acquiring an additional 1,905 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners purchased a new stake in UiPath in the 4th quarter worth $50,000. 62.50% of the stock is owned by hedge funds and other institutional investors.

UiPath Stock Performance

Shares of NYSE:PATH opened at $19.48 on Friday. The business has a 50 day simple moving average of $21.75 and a two-hundred day simple moving average of $21.65. UiPath Inc. has a 1 year low of $12.38 and a 1 year high of $27.87.

UiPath (NYSE:PATHGet Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. As a group, equities research analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. TD Cowen raised their price objective on UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, March 14th. Morgan Stanley lifted their price objective on UiPath from $17.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 14th. Needham & Company LLC reiterated a “buy” rating and set a $30.00 target price on shares of UiPath in a research report on Wednesday, March 20th. BMO Capital Markets boosted their price target on shares of UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research report on Thursday, March 14th. Finally, Truist Financial reaffirmed a “buy” rating and set a $32.00 price target on shares of UiPath in a research note on Wednesday, March 20th. Nine investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $27.41.

Get Our Latest Analysis on PATH

Insider Activity

In related news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $22.47, for a total value of $359,520.00. Following the transaction, the chief financial officer now owns 103,505 shares of the company’s stock, valued at approximately $2,325,757.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is currently owned by company insiders.

UiPath Company Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.